Moxy: The Short, Intense Psychedelic High Sweeping The Globe

Moxy, known formally as 5-MeO-MIPT, is a powerful synthetic psychedelic that has gained momentum in recent years. Initially synthesized in the 1980s, the compound remained relatively obscure until the early 2000s, when interest in psychedelics grew, particularly among those exploring their therapeutic potential. Today, Moxy is becoming increasingly popular among recreational users worldwide, noted for its brief but intense psychedelic experience.

What Is Moxy?

First synthesized in 1985 by psychedelics pioneers Alexander and Ann Shulgin and David B. Repke, Moxy is a synthetic tryptamine, chemically related to serotonin and other psychedelics like psilocybin and DMT. Its synthesis arose from tests that looked at how small changes in the chemical structure of a drug could influence the effects it produces when consumed. Despite its short duration —usually lasting 15 to 45 minutes—Moxy is highly potent, with users typically consuming doses between 2 mg and 10 mg. The experience is characterized by profound perceptual changes, vivid hallucinations and feelings of ego dissolution. Unlike longer-lasting psychedelics like LSD or psilocybin, Moxy’s effects are known for peaking quickly and subsiding within minutes, which can make the experience overwhelming for those unprepared for the intensity.

A Global Trend

Moxy’s global rise can be attributed to the growing interest in psychedelics, both for recreational and therapeutic purposes. In Europe, countries like the United …

Full story available on Benzinga.com